Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / RVMD - Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details | Benzinga

RVMD - Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details | Benzinga

Revolution Medicines Inc.

Raymond James initiated coverage on Revolution Medicines Inc (NASDAQ: RVMD), noting that the October readout of RMC-6236 was compelling compared to historical SoC.

RMC-6236 is an oral, first-in-class RAS(ON) inhibitor designed to treat patients with cancers driven by a wide range of common RAS mutations.

The analyst initiates with an Outperform rating and a target price ...

Full story available on Benzinga.com
Stock Information
Company Name: Revolution Medicines Inc.
Stock Symbol: RVMD
Market: NASDAQ
Website: revmed.com
Menu
RVMD RVMD Quote RVMD Short RVMD News RVMD Articles RVMD Message Board
Get RVMD Alerts

News, Short Squeeze, Breakout and More Instantly...